Visual outcomes after cataract surgery in patients with type 2 diabetes.
Journal
Journal of cataract and refractive surgery
ISSN: 1873-4502
Titre abrégé: J Cataract Refract Surg
Pays: United States
ID NLM: 8604171
Informations de publication
Date de publication:
04 2019
04 2019
Historique:
received:
19
07
2018
revised:
23
10
2018
accepted:
01
11
2018
pubmed:
15
1
2019
medline:
20
5
2020
entrez:
15
1
2019
Statut:
ppublish
Résumé
To assess the relation between diabetic retinopathy (DR) severity, duration of diabetes, insulin dependence, and preoperative hemoglobin A Kaiser Permanente Northern California, USA. Retrospective case series. Information was obtained from the electronic medical record for patients, June 1, 2010, through May 31, 2015. Confounding factors and clustering of eyes within patients were controlled for using linear mixed-effects regression models for continuous outcomes and general estimating equations for dichotomous outcomes. The study included 65 370 patients; 28% had type 2 diabetes without DR, 5% nonproliferative DR, and 1.2% proliferative DR. Patients with diabetes and no DR were as likely as those without diabetes to achieve a corrected distance visual acuity (CDVA) of 20/20 (odds ratio, 1.01; 95% confidence interval, 0.94-1.10). The odds of a postoperative CDVA of 20/25 or worse increased with the severity of retinopathy duration of diabetes and insulin dependence, but not with the preoperative HbA Patients with DR and cataracts were less likely to achieve a CDVA of 20/20 vision but gained as many lines of CDVA from phacoemulsification as patients without diabetes, showing no evidence that cataract surgery should be delayed in diabetic patients with elevated HbA
Identifiants
pubmed: 30638823
pii: S0886-3350(18)30920-9
doi: 10.1016/j.jcrs.2018.11.002
pmc: PMC6481649
mid: NIHMS1518367
pii:
doi:
Types de publication
Journal Article
Multicenter Study
Research Support, N.I.H., Extramural
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
404-413Subventions
Organisme : NEI NIH HHS
ID : R01 EY027329
Pays : United States
Organisme : NEI NIH HHS
ID : R21 EY022989
Pays : United States
Commentaires et corrections
Type : CommentIn
Type : CommentIn
Informations de copyright
Copyright © 2018 ASCRS and ESCRS. Published by Elsevier Inc. All rights reserved.
Références
Graefes Arch Clin Exp Ophthalmol. 2011 Mar;249(3):349-59
pubmed: 20827486
J Cataract Refract Surg. 2011 Nov;37(11):2006-12
pubmed: 21889874
Middle East Afr J Ophthalmol. 2013 Oct-Dec;20(4):293-300
pubmed: 24339678
Ophthalmology. 2016 Feb;123(2):287-94
pubmed: 26459998
Cochrane Database Syst Rev. 2018 Jan 10;1:CD006366
pubmed: 29364503
Cochrane Database Syst Rev. 2012 Sep 12;(9):CD007315
pubmed: 22972106
Ophthalmic Epidemiol. 2016;23(1):40-5
pubmed: 26766069
Acta Ophthalmol. 2014 May;92 Thesis1:1-13
pubmed: 24809766
J Clin Epidemiol. 1992 Jun;45(6):613-9
pubmed: 1607900
J Diabetes Res. 2017;2017:3459156
pubmed: 28243608
J Refract Surg. 1997 Jul-Aug;13(4):388-91
pubmed: 9268940
Ophthalmology. 2015 Dec;122(12):2450-6
pubmed: 26409728
J Cataract Refract Surg. 2017 Feb;43(2):207-214
pubmed: 28366368
Br J Ophthalmol. 2017 Dec;101(12):1673-1678
pubmed: 28487377
Ophthalmology. 2015 Nov;122(11):2159-68
pubmed: 26123091
Semin Ophthalmol. 2018;33(1):75-82
pubmed: 29144826